Susan Molineaux

Susan Molineaux

Founder bei CALITHERA BIOSCIENCES, INC.

Vermögen: 431 625 $ am 31.03.2024

70 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Susan M.
Molineaux
was the founder of Proteolix, Inc. (founded in 2003) and Calithera Biosciences, Inc. (founded in 2010), where she holds the title of Chief Scientific Officer and President, Chief Executive Officer & Director respectively.
She currently holds the position of Independent Director at Geron Corp.
(since 2012), Repare Therapeutics, Inc. (since 2023), and Smith College (since 2017).
She is also a Scientific Advisor at LSV Capital Management LLC.
In her former roles, she served as Co-Vice Chairman at The Bay Area Bioscience Association, Independent Director at Theravance Biopharma, Inc. (from 2015 to 2022), Secretary & Director at We Teach Science Foundation, Director at California Biomedical Innovation Alliance, Independent Director at Cyteir Therapeutics, Inc. (from 2020 to 2023), Director at California Life Sciences Association, Scientist-Immunology Group at Merck & Co., Inc. (from 1989 to 1994), Vice President-Drug Development at Praecis Pharmaceuticals, Inc. (from 1994 to 1999), Vice President-Biology at Rigel Pharmaceuticals, Inc. (from 2000 to 2003), and Vice President-Biology at Praelux, Inc. (from 1999 to 2000).
She obtained her undergraduate degree from Smith College and her doctorate degree from The Johns Hopkins University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
01.03.2024 130 527 ( 0,02% ) 430 739 $ 31.03.2024
30.04.2023 35 441 ( 0,73% ) 886 $ 31.03.2024
08.06.2023 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Susan Molineaux

UnternehmenPositionBeginn
GERON CORPORATION Director/Board Member 28.09.2012
CALITHERA BIOSCIENCES, INC. Founder 09.03.2010
REPARE THERAPEUTICS INC. Director/Board Member 08.06.2023
Director/Board Member 01.06.2017
Consultant / Advisor -
Alle aktiven Positionen von Susan Molineaux

Ehemalige bekannte Positionen von Susan Molineaux

UnternehmenPositionEnde
CYTEIR THERAPEUTICS, INC. Director/Board Member 26.05.2023
THERAVANCE BIOPHARMA, INC. Director/Board Member 01.01.2022
Director/Board Member 01.03.2016
Director/Board Member 01.03.2016
░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Susan Molineaux im Detail an

Ausbildung von Susan Molineaux

Smith College Undergraduate Degree
The Johns Hopkins University Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Susan Molineaux im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

17

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen7
MERCK & CO., INC.

Health Technology

GERON CORPORATION

Health Technology

RIGEL PHARMACEUTICALS, INC.

Health Technology

CALITHERA BIOSCIENCES, INC.

Health Technology

THERAVANCE BIOPHARMA, INC.

Health Technology

CYTEIR THERAPEUTICS, INC.

Health Technology

REPARE THERAPEUTICS INC.

Health Technology

Private Unternehmen8

Health Technology

Health Technology

Health Technology

The Bay Area Bioscience Association

Health Technology

We Teach Science Foundation

Health Technology

Commercial Services

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Susan Molineaux